Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 535

1.

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines.

Davitt CJH, Longet S, Albutti A, Aversa V, Nordqvist S, Hackett B, McEntee CP, Rosa M, Coulter IS, Lebens M, Tobias J, Holmgren J, Lavelle EC.

Mucosal Immunol. 2019 Jul;12(4):1055-1064. doi: 10.1038/s41385-019-0159-z. Epub 2019 Apr 5.

PMID:
30953000
2.

Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCT.

Terrinoni M, Holmgren J, Lebens M, Larena M.

Front Immunol. 2019 Feb 19;10:269. doi: 10.3389/fimmu.2019.00269. eCollection 2019.

3.
4.

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

Rattik S, Mantani PT, Yao Mattisson I, Ljungcrantz I, Sundius L, Björkbacka H, Terrinoni M, Lebens M, Holmgren J, Nilsson J, Wigren M, Nordin Fredrikson G.

Vascul Pharmacol. 2018 Dec;111:54-61. doi: 10.1016/j.vph.2018.09.002. Epub 2018 Sep 19.

PMID:
30243560
5.

Global nursing as visualised on the internet: a netnographic analysis of the emerging global paradigm in nursing.

Holmgren J, Eriksson H, Tegnestedt C.

Contemp Nurse. 2018 Aug - Oct;54(4-5):443-455. doi: 10.1080/10376178.2018.1524265. Epub 2018 Sep 20.

PMID:
30235985
6.

Evidence for magnitude representations of social hierarchies: Size and distance effects.

Holmgren J, Isager PM, Schubert TW.

PLoS One. 2018 Sep 7;13(9):e0203263. doi: 10.1371/journal.pone.0203263. eCollection 2018.

7.

Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.

Holmgren J, Nordqvist S, Blomquist M, Jeverstam F, Lebens M, Raghavan S.

Vaccine. 2018 Oct 1;36(41):6223-6230. doi: 10.1016/j.vaccine.2018.07.073. Epub 2018 Aug 14.

PMID:
30119923
8.

Morphine reduced perceived anger from neutral and implicit emotional expressions.

Løseth GE, Eikemo M, Isager P, Holmgren J, Laeng B, Vindenes V, Hjørnevik T, Leknes S.

Psychoneuroendocrinology. 2018 May;91:123-131. doi: 10.1016/j.psyneuen.2018.02.035. Epub 2018 Mar 1.

PMID:
29550675
9.

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae.

Terrinoni M, Nordqvist SL, Källgård S, Holmgren J, Lebens M.

Appl Environ Microbiol. 2018 Jan 31;84(4). pii: e02143-17. doi: 10.1128/AEM.02143-17. Print 2018 Feb 15.

10.

Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation.

Longet S, Aversa V, O'Donnell D, Tobias J, Rosa M, Holmgren J, Coulter IS, Lavelle EC.

Int J Pharm. 2017 Dec 20;534(1-2):60-70. doi: 10.1016/j.ijpharm.2017.10.013. Epub 2017 Oct 9.

PMID:
29024788
11.

Global nursing in an Ebola viral haemorrhagic fever outbreak: before, during and after deployment.

von Strauss E, Paillard-Borg S, Holmgren J, Saaristo P.

Glob Health Action. 2017;10(1):1371427. doi: 10.1080/16549716.2017.1371427.

12.

Deficiency in Calcium-Binding Protein S100A4 Impairs the Adjuvant Action of Cholera Toxin.

Sun JB, Holmgren J, Larena M, Terrinoni M, Fang Y, Bresnick AR, Xiang Z.

Front Immunol. 2017 Sep 11;8:1119. doi: 10.3389/fimmu.2017.01119. eCollection 2017.

13.

Correlates of protection for enteric vaccines.

Holmgren J, Parashar UD, Plotkin S, Louis J, Ng SP, Desauziers E, Picot V, Saadatian-Elahi M.

Vaccine. 2017 Jun 8;35(26):3355-3363. doi: 10.1016/j.vaccine.2017.05.005. Epub 2017 May 11.

PMID:
28504192
14.

Cholera.

Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J.

Lancet. 2017 Sep 23;390(10101):1539-1549. doi: 10.1016/S0140-6736(17)30559-7. Epub 2017 Mar 13. Review.

PMID:
28302312
15.

Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.

Tobias J, Lebens M, Wai SN, Holmgren J, Svennerholm AM.

Microb Pathog. 2017 Apr;105:177-184. doi: 10.1016/j.micpath.2017.02.021. Epub 2017 Feb 17.

PMID:
28215587
16.
17.

Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process.

Karlsson SL, Thomson N, Mutreja A, Connor T, Sur D, Ali M, Clemens J, Dougan G, Holmgren J, Lebens M.

PLoS Negl Trop Dis. 2016 Oct 5;10(10):e0005044. doi: 10.1371/journal.pntd.0005044. eCollection 2016 Oct.

18.

Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea.

Borde A, Ekman A, Larsson A, Carlin N, Holmgren J, Tobias J.

Eur J Pharm Biopharm. 2016 Nov;108:18-24. doi: 10.1016/j.ejpb.2016.07.011. Epub 2016 Jul 30.

PMID:
27485398
19.

A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens.

Davitt CJ, McNeela EA, Longet S, Tobias J, Aversa V, McEntee CP, Rosa M, Coulter IS, Holmgren J, Lavelle EC.

J Control Release. 2016 Jul 10;233:162-73. doi: 10.1016/j.jconrel.2016.05.001. Epub 2016 May 5.

PMID:
27157995
20.

Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.

Lebens M, Terrinoni M, Karlsson SL, Larena M, Gustafsson-Hedberg T, Källgård S, Nygren E, Holmgren J.

Vaccine. 2016 Apr 19;34(18):2121-8. doi: 10.1016/j.vaccine.2016.03.002. Epub 2016 Mar 11.

PMID:
26973069
21.

Space GlucoseControl system for blood glucose control in intensive care patients--a European multicentre observational study.

Blaha J, Barteczko-Grajek B, Berezowicz P, Charvat J, Chvojka J, Grau T, Holmgren J, Jaschinski U, Kopecky P, Manak J, Moehl M, Paddle J, Pasculli M, Petersson J, Petros S, Radrizzani D, Singh V, Starkopf J.

BMC Anesthesiol. 2016 Jan 22;16:8. doi: 10.1186/s12871-016-0175-4.

22.

Vaccines against enteric infections for the developing world.

Czerkinsky C, Holmgren J.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). pii: 20150142. doi: 10.1098/rstb.2015.0142. Review.

23.

Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling.

Larena M, Holmgren J, Lebens M, Terrinoni M, Lundgren A.

J Immunol. 2015 Apr 15;194(8):3829-39. doi: 10.4049/jimmunol.1401633. Epub 2015 Mar 18.

24.

Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.

Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, Holmgren J, Petzold M, Walker R, Svennerholm AM.

Vaccine. 2014 Dec 12;32(52):7077-84. doi: 10.1016/j.vaccine.2014.10.069. Epub 2014 Nov 5.

25.

Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.

Karlsson SL, Ax E, Nygren E, Källgård S, Blomquist M, Ekman A, Benktander J, Holmgren J, Lebens M.

PLoS One. 2014 Nov 14;9(11):e108521. doi: 10.1371/journal.pone.0108521. eCollection 2014.

26.

Natural evolution and human consciousness.

Holmgren J.

Mens Sana Monogr. 2014 Jan;12(1):127-38. doi: 10.4103/0973-1229.130322.

27.

Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.

Kanungo S, Lopez AL, Ali M, Manna B, Kim DR, Mahapatra T, Holmgren J, Dhingra MS, Weirzba TF, Nair GB, Bhattacharya SK, Clemens JD, Sur D.

PLoS One. 2014 May 6;9(5):e96499. doi: 10.1371/journal.pone.0096499. eCollection 2014.

28.

Nursing under the skin: a netnographic study of metaphors and meanings in nursing tattoos.

Eriksson H, Christiansen M, Holmgren J, Engström A, Salzmann-Erikson M.

Nurs Inq. 2014 Dec;21(4):318-26. doi: 10.1111/nin.12061. Epub 2014 Jan 28.

PMID:
24467822
29.

When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?

Clemens J, Holmgren J.

Curr Top Microbiol Immunol. 2014;379:231-58. doi: 10.1007/82_2013_353. Review.

PMID:
24402712
30.

Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditions.

Cobaxin M, Martínez H, Ayala G, Holmgren J, Sjöling A, Sánchez J.

Microb Pathog. 2014 Jan;66:5-13. doi: 10.1016/j.micpath.2013.11.002. Epub 2013 Nov 14.

PMID:
24239941
31.

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD.

Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011.

PMID:
24140390
32.

Important role for FcγRIIB on B lymphocytes for mucosal antigen-induced tolerance and Foxp3+ regulatory T cells.

Sun JB, Xiang Z, Smith KG, Holmgren J.

J Immunol. 2013 Oct 15;191(8):4412-22. doi: 10.4049/jimmunol.1301324. Epub 2013 Sep 13.

33.

Intersectional perspectives on family involvement in nursing home care: rethinking relatives' position as a betweenship.

Holmgren J, Emami A, Eriksson LE, Eriksson H.

Nurs Inq. 2014 Sep;21(3):227-37. doi: 10.1111/nin.12046. Epub 2013 Jul 23.

PMID:
23875545
34.

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.

Vaccine. 2013 May 7;31(20):2457-64. doi: 10.1016/j.vaccine.2013.03.027. Epub 2013 Mar 27.

35.

A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.

Sjökvist Ottsjö L, Flach CF, Clements J, Holmgren J, Raghavan S.

Infect Immun. 2013 May;81(5):1532-40. doi: 10.1128/IAI.01407-12. Epub 2013 Feb 25.

36.

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.

Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, Jertborn M, Bourgeois L, Walker R, Holmgren J, Svennerholm AM.

Vaccine. 2013 Feb 6;31(8):1163-70. doi: 10.1016/j.vaccine.2012.12.063. Epub 2013 Jan 7.

PMID:
23306362
37.

Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.

Kang SS, Yang JS, Kim KW, Yun CH, Holmgren J, Czerkinsky C, Han SH.

Mucosal Immunol. 2013 Jul;6(4):826-37. doi: 10.1038/mi.2012.121. Epub 2012 Nov 28.

PMID:
23187318
38.

Being perceived as a 'visitor' in the nursing staff's working arena--the involvement of relatives in daily caring activities in nursing homes in an urban community in Sweden.

Holmgren J, Emami A, Eriksson LE, Eriksson H.

Scand J Caring Sci. 2013 Sep;27(3):677-85. doi: 10.1111/j.1471-6712.2012.01077.x. Epub 2012 Sep 25.

PMID:
23003575
39.

Effect of protein release rates from tablet formulations on the immune response after sublingual immunization.

Borde A, Ekman A, Holmgren J, Larsson A.

Eur J Pharm Sci. 2012 Nov 20;47(4):695-700. doi: 10.1016/j.ejps.2012.08.014. Epub 2012 Aug 29.

PMID:
22959953
40.

A case for control of cholera in Africa by vaccination.

Holmgren J.

Lancet Infect Dis. 2012 Nov;12(11):818-9. doi: 10.1016/S1473-3099(12)70204-9. Epub 2012 Sep 4. No abstract available.

PMID:
22954656
41.

Migration routes and strategies in a highly aerial migrant, the common swift Apus apus, revealed by light-level geolocators.

Åkesson S, Klaassen R, Holmgren J, Fox JW, Hedenström A.

PLoS One. 2012;7(7):e41195. doi: 10.1371/journal.pone.0041195. Epub 2012 Jul 18.

42.

Vaccines against mucosal infections.

Holmgren J, Svennerholm AM.

Curr Opin Immunol. 2012 Jun;24(3):343-53. doi: 10.1016/j.coi.2012.03.014. Epub 2012 May 12. Review.

43.
44.

Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.

Flach CF, Mozer M, Sundquist M, Holmgren J, Raghavan S.

Vaccine. 2012 Feb 21;30(9):1636-43. doi: 10.1016/j.vaccine.2011.12.111. Epub 2012 Jan 9.

PMID:
22230589
45.

New-generation vaccines against cholera.

Clemens J, Shin S, Sur D, Nair GB, Holmgren J.

Nat Rev Gastroenterol Hepatol. 2011 Nov 8;8(12):701-10. doi: 10.1038/nrgastro.2011.174. Review.

PMID:
22064524
46.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18.

47.

Detection of human papillomavirus oncoprotein E7 in liquid-based cytology.

Lidqvist M, Nilsson O, Holmgren J, Hölters S, Röijer E, Dürst M, Fermér C.

J Gen Virol. 2012 Feb;93(Pt 2):356-63. doi: 10.1099/vir.0.034884-0. Epub 2011 Oct 19.

PMID:
22012460
48.

Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.

Tobias J, Svennerholm AM, Carlin NI, Lebens M, Holmgren J.

Vaccine. 2011 Nov 8;29(48):8863-9. doi: 10.1016/j.vaccine.2011.09.096. Epub 2011 Oct 6.

PMID:
21983363
49.

Evidence for several waves of global transmission in the seventh cholera pandemic.

Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, Croucher NJ, Choi SY, Harris SR, Lebens M, Niyogi SK, Kim EJ, Ramamurthy T, Chun J, Wood JL, Clemens JD, Czerkinsky C, Nair GB, Holmgren J, Parkhill J, Dougan G.

Nature. 2011 Aug 24;477(7365):462-5. doi: 10.1038/nature10392.

50.

Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.

Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.

Vaccine. 2011 Oct 6;29(43):7505-13. doi: 10.1016/j.vaccine.2011.06.121. Epub 2011 Jul 30.

PMID:
21807059

Supplemental Content

Loading ...
Support Center